Clinical Trial Update: A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating two doses of the tetravalent dengue vaccine (TDV) in infants and toddlers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Tetravalent Dengue Vaccine (TDV) (tetravalent dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Dengue Fever | Phase 3 | Status: RECRUITING